These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32070646)

  • 1. Retraction notice to "miR-149 regulates the proliferation and apoptosis of cervical canc er cells by targeting GIT1" [Biomed. Pharmacother. 105 (2018) 1106-1116].
    Qian B; Zhao L; Wang X; Xu J; Teng F; Gao L; Shen R
    Biomed Pharmacother; 2020 May; 125():109971. PubMed ID: 32070646
    [No Abstract]   [Full Text] [Related]  

  • 2. Retraction Notice to "MicroRNA138 regulates keratin 17 protein expression to affect HaCaT cell proliferation and apoptosis by targeting hTERT in psoriasis vulgaris" [Biomed. Pharmacother. 85 (2017) 169 - 176].
    Feng SJ; Chu RQ; Ma J; Wang ZX; Zhang GJ; Yang XF; Song Z; Ma YY
    Biomed Pharmacother; 2023 Sep; 165():114742. PubMed ID: 37164830
    [No Abstract]   [Full Text] [Related]  

  • 3. Retraction notice to "LNCRNA CDKN2B-AS1 regulates mesangial cell proliferation and extracellular matrix accumulation via miR-424-5p/HMGA2 axis" [Biomed. Pharmacother. 121 (2020) 109622].
    Li Y; Zheng LL; Huang DG; Cao H; Gao YH; Fan ZC
    Biomed Pharmacother; 2023 Aug; 164():114728. PubMed ID: 37087341
    [No Abstract]   [Full Text] [Related]  

  • 4. Retraction notice to "Protection of rats spinal cord ischemia-reperfusion injury by inhibition of MiR-497 on inflammation and apoptosis: Possible role in pediatrics" [Biomed. Pharmacother. 81 (2016) 337-344].
    Xu M; Wang HF; Zhang YY; Zhuang HW
    Biomed Pharmacother; 2018 Feb; 98():927. PubMed ID: 29421863
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer" [Biomed. Pharmacother. 95 (2017) 1718-1724].
    Lin Y; Cheng K; Wang T; Xie Q; Chen M; Chen Q; Wen Q
    Biomed Pharmacother; 2024 Feb; 171():116187. PubMed ID: 38296728
    [No Abstract]   [Full Text] [Related]  

  • 6. Retraction notice to "Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a" [Biomed. Pharmacother. 112 (2019) 108592].
    Xu F; Li Q; Wang Z; Cao X
    Biomed Pharmacother; 2022 Apr; 148():112781. PubMed ID: 35272893
    [No Abstract]   [Full Text] [Related]  

  • 7. Retraction notice to "miR-217 represses TGF-β1-induced airway smooth muscle cell proliferation and migration through targeting ZEB1 " [Biomed. Pharmacother. 108 (2018) 27-35].
    Gao Y; Wang B; Luo H; Zhang Q; Xu M
    Biomed Pharmacother; 2023 Sep; 165():114805. PubMed ID: 37183050
    [No Abstract]   [Full Text] [Related]  

  • 8. Retraction notice to "TUG1 alleviates hypoxia injury by targeting miR-124 in H9c2 cells" [Biomed. Pharmacother. 103 (2018) 1669-1677].
    Jiang N; Xia J; Jiang B; Xu Y; Li Y
    Biomed Pharmacother; 2022 Jun; 150():112856. PubMed ID: 35341638
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraction notice to "miR-208b targets Bax to protect H9c2 cells against hypoxia-induced apoptosis" [Biomed. Pharmacother. 106 (2018) 1751-1759].
    Zhou YL; Sun Q; Zhang L; Li R
    Biomed Pharmacother; 2022 Apr; 148():112714. PubMed ID: 35164994
    [No Abstract]   [Full Text] [Related]  

  • 10. Retraction notice to "Neferine inhibits proliferation, migration and invasion of U251 glioma cells by down-regulation of miR-10b" [Biomed. Pharmacother. 109 (2019) 1032-1040].
    Liang HX; Sun LB; Liu NJ
    Biomed Pharmacother; 2021 Dec; 144():112388. PubMed ID: 34772580
    [No Abstract]   [Full Text] [Related]  

  • 11. Retraction notice to "Alkannin inhibits proliferation, migration and invasion of hepatocellular carcinoma cells via regulation of miR-92a" [Biomed. Pharmacother. 114 (2019) 108782].
    Sun B; Zhang J; Liu M; Guan L
    Biomed Pharmacother; 2022 Feb; 146():112626. PubMed ID: 35031232
    [No Abstract]   [Full Text] [Related]  

  • 12. Retraction notice to "MiR-539 inhibits human colorectal cancer progression by targeting RUNX2″ [Biomed. Pharmacother. 95 (2017) 1314-1320].
    Wen D; Li S; Jiang W; Zhu J; Liu J; Zhao S
    Biomed Pharmacother; 2023 Nov; 167():115375. PubMed ID: 37802728
    [No Abstract]   [Full Text] [Related]  

  • 13. Retraction notice to "Long non-coding RNA TUG1 inhibits apoptosis and inflammatory response in LPS-treated H9c2 cells by down-regulation of miR-29b" [Biomed. Pharmacother. 101 (2018) 663-669].
    Zhang H; Li H; Ge A; Guo E; Liu S; Zhang L
    Biomed Pharmacother; 2022 Apr; 148():112716. PubMed ID: 35164992
    [No Abstract]   [Full Text] [Related]  

  • 14. Retraction notice to "LncRNA SNHG16 promotes tumor growth of pancreatic cancer by targeting miR-218-5p" [Biomed. Pharmacother. 114 (2019) 108862].
    Liu S; Zhang W; Liu K; Liu Y
    Biomed Pharmacother; 2024 Feb; 171():116188. PubMed ID: 38296726
    [No Abstract]   [Full Text] [Related]  

  • 15. Retraction notice to "Icaritin induces mitochondrial apoptosis by up-regulating miR-124 in human oral squamous cell carcinoma cells" [Biomed. Pharmacother. 85 (2017) 287-295].
    Jin L; Miao J; Liu Y; Li X; Jie Y; Niu Q; Han X
    Biomed Pharmacother; 2024 Sep; 178():117169. PubMed ID: 39048392
    [No Abstract]   [Full Text] [Related]  

  • 16. Retraction notice to "miR-367 regulation of DOC-2/DAB2 interactive protein promotes proliferation, migration and invasion of osteosarcoma cells" [Biomed. Pharmacother. 95 (2017) 120-128].
    Cai W; Jiang H; Yu Y; Xu Y; Zuo W; Wang S; Su Z
    Biomed Pharmacother; 2023 Apr; 160():114282. PubMed ID: 36725469
    [No Abstract]   [Full Text] [Related]  

  • 17. Retraction notice to "miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1" [Biomed. Pharmacother. 106 (2018) 1072-1081].
    Deng H; Geng Q; Ji T; Yang A
    Biomed Pharmacother; 2023 Jun; 162():114720. PubMed ID: 37087344
    [No Abstract]   [Full Text] [Related]  

  • 18. Retraction notice to "LncRNA DICER1-AS1 promotes the proliferation, invasion and autophagy of osteosarcoma cells via miR-30b/ATG5" [Biomed. Pharmacother., 104 (2018) 110-118].
    Gu Z; Hou Z; Zheng L; Wang X; Wu L; Zhang C
    Biomed Pharmacother; 2024 Mar; 172():116198. PubMed ID: 38296734
    [No Abstract]   [Full Text] [Related]  

  • 19. Retraction notice to "MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC" Biomed. Pharmacother. 110(2019) 656-666.
    Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
    Biomed Pharmacother; 2024 Aug; 177():117098. PubMed ID: 38971639
    [No Abstract]   [Full Text] [Related]  

  • 20. Retraction notice to "Ailanthone exerts anticancer effect by up-regulating miR-148a expression in MDA-MB-231 breast cancer cells and inhibiting proliferation, migration and invasion" [Biomed. Pharmacother. 109 (2019) 1062-1069].
    Gao W; Ge S; Sun J
    Biomed Pharmacother; 2022 Jun; 150():112854. PubMed ID: 35341636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.